HealthcareSunesis files shelf offeringMay 07, 2014 5:12 PM ETViracta Therapeutics, Inc. (VIRX) StockVIRXBy: Douglas W. House, SA News Editor Sunesis Pharmaceuticals (SNSS -4.6%) files a $200M shelf offering of common and preferred stock, debt and warrants. Proceeds to be used for working capital and general corporate purposes. S-3 Recommended For YouMore Trending NewsSee More »About VIRX StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgVIRX--Viracta Therapeutics, Inc.Trending AnalysisTrending News